Skip to main content

Table 2 Perioperative variables in patients undergoing aortic valve replacement surgery

From: Effects of transcutaneous electrical nerve stimulation on myocardial protection in patients undergoing aortic valve replacement: a randomized clinical trial

 

PRE

(n = 5)

s-PRE

(n = 5)

SEVO

(n = 5)

s-SEVO

(n = 5)

PPF

(n = 5)

s-PPF

(n = 5)

p-value

Operation duration (min)

314 ± 49

326 ± 82

219 ± 54

321 ± 82

227 ± 43

288 ± 108

0.089

Anesthesia duration (min)

370 ± 52

400 ± 87

279 ± 50

380 ± 85

290 ± 42

347 ± 109

0.102

Cardiopulmonary bypass duration (min)

171 ± 38

177 ± 61

111 ± 37

163 ± 51

107 ± 11

125 ± 33

0.036

Aorta cross-clamp duration (min)

130 ± 44

111 ± 49

85 ± 30

109 ± 52

72 ± 7

83 ± 29

0.193

Type of cardioplegia

      

0.004

 HTK solution

5 (100%)

3 (60%)

1 (20%)

1 (20%)

0 (0%)

0 (0%)

 

 Del Nido

0 (0%)

2 (40%)

4 (80%)

4 (80%)

5 (100%)

5 (100%)

 

Total dosage of cardioplegia (L)

4.0 (4.0–4.5)

3.0 (1.5–4.5)

2.0 (1.1–3.0)

1.3 (1.2–4.4)

1.2 (1.0–1.8)

1.2 (1.0–1.8)

0.037

Nadir nasal temperature (°C)

27.6 ± 1.7

29.2 ± 1.8

29.4 ± 2.0

29.6 ± 2.9

30.6 ± 1.8

29.3 ± 2.6

0.388

Nadir rectal temperature (°C)

29.1 ± 2.0

29.9 ± 1.5

30.8 ± 0.6

30.1 ± 3.0

31.8 ± 0.8

30.5 ± 2.4

0.266

Intraoperative RBC transfusion (unit)

0 (0–0 [0–0])

0 (0–0 [0–0])

0 (0–1 [0–1])

0 (0–1 [0–1])

0 (0–0 [0–1])

0 (0–0 [0–2])

0.477

Intraoperative FFP transfusion (unit)

0 (0–2 [0–3])

3 (2–3 [0–3])

2 (0–3 [0–3])

0 (0–3 [0–3])

0 (0–0 [0–0])

0 (0–3 [0–3])

0.271

Intraoperative plateletpheresis transfusion (unit)

0 (0–0 [0–1])

1 (0–1 [0–1])

0 (0–1 [0–2])

0 (0–1 [0–2])

0 (0–0 [0–0])

0 (0–0 [0–1])

0.425

Postoperative RBC transfusion (unit)

2 (1–2 [0–5])

2 (1–3 [0–8])

0 (0–0 [0–5])

2 (0–2 [0–3])

0 (0–1 [0–2])

1 (0–3 [0–4])

0.507

Postoperative FFP transfusion (unit)

0 (0–2 [0–4])

1 (0–2 [0–3])

0 (0–0 [0–4])

0 (0–0 [0–1])

0 (0–0 [0–1])

0 (0–1 [0–1])

0.626

Postoperative plateletpheresis transfusion (unit)

1 (0–1 [0–2])

2 (1–2 [0–6])

0 (0–0 [0–1])

0 (0–0 [0–3])

0 (0–0 [0–1])

0 (0–1 [0–2])

0.194

Peak postoperative troponin I within 72 h (ng/mL)

9.31 (7.38–38.51)

24.92 (6.95–185.85)

4.31 (2.61–19.93)

13.35 (4.21–92.68)

6.69 (3.48–7.93)

6.18 (4.61–27.01)

0.317

Postoperative atrial fibrillation

0 (0%)

1 (20%)

1 (20%)

1 (20%)

2 (40%)

1 (20%)

0.974

Re-exploration

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

N/A

In-hospital stroke

0 (0%)

0 (0%)

1 (20%)

1 (20%)

0 (0%)

0 (0%)

0.509

In-hospital myocardial infarction

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

N/A

In-hospital mortality

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

N/A

  1. Data are presented as mean ± SD, median (interquartile range [range]), or number (%)
  2. TENS transcutaneous electrical nerve stimulation, SEVO sevoflurane, PPF propofol, HTK histidine-tryptophan-ketoglutarate, RBC red blood cell, FFP fresh frozen plasma